TrialsgrambetaRCTs are beautiful

DanGer Shock

2024

Microaxial Flow Pump in Infarct-Related Cardiogenic Shock

In 360 patients with STEMI-related cardiogenic shock, a microaxial flow pump (Impella CP) reduced 180-day all-cause mortality compared with standard care.

Result

Efficacy: All-cause mortality at 180 daysHR 0.74

Below 1 favours microaxial flow pump (Impella CP), above 1 favours standard care.

Event rates
Absolute difference
12.7 points

The absolute difference is derived from the event rates.

Also reported: NNT 8). More severe bleeding, limb ischaemia, haemolysis and renal failure.

Original publication
Subtopic
Cardiogenic shock
Design
RCT, 180-day follow-up
Relevance
Important: one of several pillars.
Source
Møller JE, et al. N Engl J Med. 2024;390(15):1382-1393.doi 10.1056/NEJMoa2312572

Discussion & critique

First positive mechanical-support RCT in AMI cardiogenic shock, but strict selection (STEMI, no prolonged-resuscitation arrest). ACC/AHA 2024 class IIa. Complications are frequent: patient selection is everything.

Discussed in podcasts